Brought to you by 
LensAR brings in up to $60mm through debt financing
01 Nov 2013
Executive Summary
PDL BioPharma Inc. is providing LensAR Inc. with up to $60mm in debt financing. It received $40mm up front and will get an additional $20mm by September 30, 2014 upon reaching a predetermined sales milestone. The loan has a 15.5% interest rate per annum and is payable quarterly. In exchange, PDL was given a security interest in all of LensAR's assets and will get interest on the outstanding principal. The money will be used to expand commercialization of LensAR’s refractive lasers for cataract surgery throughout North America, Europe, Asia, Latin America, and other markets.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LensAR brings in up to $60mm through debt financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice